Clinical Trials Directory

Trials / Conditions / Refractory Glioblastoma

Refractory Glioblastoma

7 registered clinical trials studyying Refractory Glioblastoma — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingB7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory Gliobl
NCT07193628
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 1
UnknownB7-H3 CAR-T for Recurrent or Refractory Glioblastoma
NCT04077866
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 1 / Phase 2
UnknownPilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma
NCT04385173
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 1
UnknownPilot Study of Elemene in Treating Patients With Refractory Glioblastoma
NCT04674527
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 2
RecruitingIL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM
NCT04003649
City of Hope Medical CenterPhase 1
Active Not RecruitingGenetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
NCT02208362
City of Hope Medical CenterPhase 1
No Longer AvailableExpanded Access to Gallium Maltolate (GaM)
NCT06404034
Imaging Biometrics, LLC—